202 related articles for article (PubMed ID: 23265445)
1. Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine.
Mark TL; Dilonardo J; Vandivort R; Miller K
J Subst Abuse Treat; 2013; 44(5):481-7. PubMed ID: 23265445
[TBL] [Abstract][Full Text] [Related]
2. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
[TBL] [Abstract][Full Text] [Related]
3. Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model.
Pade PA; Cardon KE; Hoffman RM; Geppert CM
J Subst Abuse Treat; 2012 Dec; 43(4):446-50. PubMed ID: 22980449
[TBL] [Abstract][Full Text] [Related]
4. Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction.
Kraus ML; Alford DP; Kotz MM; Levounis P; Mandell TW; Meyer M; Salsitz EA; Wetterau N; Wyatt SA;
J Addict Med; 2011 Dec; 5(4):254-63. PubMed ID: 22042215
[TBL] [Abstract][Full Text] [Related]
5. Primary care patient characteristics associated with completion of 6-month buprenorphine treatment.
Neumann AM; Blondell RD; Azadfard M; Nathan G; Homish GG
Addict Behav; 2013 Nov; 38(11):2724-8. PubMed ID: 23934003
[TBL] [Abstract][Full Text] [Related]
6. Urinalysis-based comparative evaluation of pattern of use of dextropropoxyphene and buprenorphine among opioid-dependent subjects.
Balhara YP; Jain R
J Opioid Manag; 2012; 8(1):45-9. PubMed ID: 22479884
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine for chronic pain.
Calderon R; Copenhaver D
J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):402-5. PubMed ID: 24245573
[TBL] [Abstract][Full Text] [Related]
8. When opioids fail in chronic pain management: the role for buprenorphine and hospitalization.
Berland DW; Malinoff HL; Weiner MA; Przybylski R
Am J Ther; 2013; 20(4):316-21. PubMed ID: 23584313
[TBL] [Abstract][Full Text] [Related]
9. Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs.
Nordbø A; Skurtveit S; Borchgrevink PC; Kaasa S; Fredheim OM
Acta Anaesthesiol Scand; 2012 Jan; 56(1):88-94. PubMed ID: 22092357
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
11. Opioid dependence - management in general practice.
Frei M
Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
[TBL] [Abstract][Full Text] [Related]
12. Chronic pain and depression among primary care patients treated with buprenorphine.
Stein MD; Herman DS; Bailey GL; Straus J; Anderson BJ; Uebelacker LA; Weisberg RB
J Gen Intern Med; 2015 Jul; 30(7):935-41. PubMed ID: 25678375
[TBL] [Abstract][Full Text] [Related]
13. Office-based buprenorphine treatment for opioid-dependent patients.
McCance-Katz EF
Harv Rev Psychiatry; 2004; 12(6):321-38. PubMed ID: 15764468
[TBL] [Abstract][Full Text] [Related]
14. The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine.
Clark RE; Samnaliev M; Baxter JD; Leung GY
Health Aff (Millwood); 2011 Aug; 30(8):1425-33. PubMed ID: 21821560
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
[TBL] [Abstract][Full Text] [Related]
16. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder.
Seal KH; Maguen S; Bertenthal D; Batki SL; Striebel J; Stein MB; Madden E; Neylan TC
J Clin Psychiatry; 2016 Sep; 77(9):1182-1188. PubMed ID: 27035058
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of buprenorphine maintenance in office-based practice.
Magura S; Lee SJ; Salsitz EA; Kolodny A; Whitley SD; Taubes T; Seewald R; Joseph H; Kayman DJ; Fong C; Marsch LA; Rosenblum A
J Addict Dis; 2007; 26(2):13-23. PubMed ID: 17594994
[TBL] [Abstract][Full Text] [Related]
18. Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey.
Nordmann S; Frauger E; Pauly V; Orléans V; Pradel V; Mallaret M; Thirion X; Micallef J
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):184-90. PubMed ID: 22109894
[TBL] [Abstract][Full Text] [Related]
19. Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphine.
Guo AY; Ma JD; Best BM; Atayee RS
J Anal Toxicol; 2013; 37(9):636-41. PubMed ID: 24080973
[TBL] [Abstract][Full Text] [Related]
20. Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.
Barry DT; Cutter CJ; Beitel M; Kerns RD; Liong C; Schottenfeld RS
J Clin Psychiatry; 2016 Oct; 77(10):1413-1419. PubMed ID: 27574837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
